ERBB4 and osteosarcoma: ERBB4 leads to activation of PI3K-AKT, focal adhesion kinase (FAK) and the RAC1 GTPase, a mediator of cell migration and invasion [24], pathways that are already been described in osteosarcoma pathogenesis [49–50].